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Papua New Guinea (PNG) recently did not secure external funding for the continuation of its antiretroviral treatment (ART)
programs meaning that supplies of HIV drugs for the estimated 38,000 people living with HIV in PNG could be completely
depleted during2010.Usinga mathematicalmodel ofHIV transmissioncalibrated to availableHIVepidemiology data from PNG,
we evaluated the expected population-level impact of reductions in ART availability. If the number of people on ART falls to 10%
of its current level, then there could be an approximately doubling in annual incidence and an additional 12,848 AIDS-related
deaths (100.7% increase) over the next 5 years; if ART provision is halved, then annual incidence would increase by ∼68%, and
there would be anadditional ∼10,936 AIDS-related deaths (85.7% increase). These results highlight that maintenanceof ART and
associated services through external funding is essential for the health and well-being of HIV-positive people in PNG.
1.Introduction
Papua New Guinea (PNG) is a low income country that
has experienced a rapidly expanding HIV epidemic [1–3].
It has the highest HIV prevalence and incidence rate in
the Paciﬁc region [1] with 28,294 HIV infections reported
by December 2008 since the ﬁrst diagnosed case in 1987
[2]. The vast majority of HIV cases have been due to
heterosexualtransmission with similar numbers ofdiagnoses
in men and women [2, 3]. Fortunately, recent estimates
suggest there has been a leveling out of HIV prevalence
in PNG at approximately 1% [4]. The reasons for this
leveling of prevalence are currently unknown but could
be due to the saturation of HIV in particular at risk
population groups or geographic areas, or reﬂect the impact
of the roll-out of intervention programs in recent years
and the successful scale-up of antiretroviral therapy (ART)
services across the country. ART ﬁrst became available
in PNG in 2004 and the PNG National Department of
Health recently estimated that more than 70% of peo-
ple requiring treatment were receiving it in 2009 [2,
4].
Despite experiencing high levels of economic growth,
mainly from the natural resources sector, PNG has limited
resources available for its HIV programs and treatment
services[5,6].Inaddition,thedistributionoftheseprograms
a n ds e r v i c e si sl i m i t e db yal a c ko fi n f r a s t r u c t u r ea n d
transport facilities due to PNG’s mountainous and rugged
terrain; over 85% of the population live in rural areas with
only 3% of roads paved and many villages can only be
accessed by foot [6]. Almost all of its resources for HIV
services in PNG rely on external sources and in early 2010
PNG did not secure funding from the Global Fund for
the continuation of its ART programs. This could have
resulted in the complete depletion of ART. Fortunately,
the PNG government provided resources to cover the costs
of PNG’s ART programs until the next round of funding
in 2011 but has not been able to continue expansion of
ART rollout. Without this government intervention, which
impacts onanalready limitedandconstrained healthbudget,
the availability of life-sustaining ART would likely have
had a large impact on the health and well-being of HIV-
infected people in PNG and potentially result in a worsening
epidemic.2 AIDS Research and Treatment
To investigate the potential population-level impact of
a rapid fall in ART supplies in PNG, we developed a
mathematical model to describe the HIV epidemic in PNG
incorporating country speciﬁc demographic, epidemiologi-
cal, behavioral, and clinical data. This model was calibrated
to accurately reﬂect the estimated HIV incidence and
prevalence, the number of recorded HIV diagnoses, and the
number of people on ART in PNG. The model was then
used to forecast the epidemictrajectory and number ofAIDS
deaths over the next 5 years under scenarios that the number
of people receiving ART: (i) continues to increase following
current trends, (ii) is maintained at the 2009 number, (iii)
decreases by 50%, and (iv) decreases by 90%. We also
investigated scenarios where there was a decrease by 50%
and 90% for a two-year period before the re-establishment
of the current roll–out; this coincides with the next round
of possible funding from the Global Fund. Considering the
limited antiretroviral stockpiles in PNG and reliance on
foreign funds, scenarios involving substantial declines in
ART access are not unrealistic.
2.Materialsand Methods
A mathematical HIV transmission model was developed
to describe the history of the HIV epidemic in PNG and
to forecast potential epidemic trends in the future due to
reductions in ART availability. All model simulations were
executed with Matlab R2009a.
2.1. Model Speciﬁcations. The HIV transmission model
describes the movement between twelve population com-
partments within both urban and rural sexually active
populations. Urban HIV susceptible individuals (Su)m a y
become infected based on probabilistic rates that inform
a deterministic “force of infection”. Newly infected indi-
viduals enter into the undiagnosed chronic/asymptomatic
stage (Cu
u). Chronically infected individuals can progress to
advancedHIV/AIDS(Au
u)andpeopleinchronicoradvanced
HIV stage can become diagnosed with their infection (Cd
u,
Ad
u). Only diagnosed advanced HIV patients can begin ART
(Tu). The same model applies to the rural population with
similar disease stages, denoted by Sr, Cu
r ,Cd
r , Au
r, Ad
r,a n d
Tr. A schematic diagram of the model is shown in Figure 1.
In the model, individuals can migrate between urban and
rural settings while remaining in the same disease stage and
sexual mixing occurs among people in the same (urban or
rural) setting. It isassumed thatARTpatientsremain at their
current location for treatment services.
The overall population-level transmission and disease
progression of HIV is described by the following set of
equations:
dSx
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where πx and Λx denote the entry rate into the population
and force of infection, respectively,
πx = ρ

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
,( 2 )
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,( 3 )
and the subscripts x, y = u,r denote urban and rural
populations. The deﬁnition of each parameter in these
equations is given in Table 1.
To evaluate the impact of HIV treatment on transmis-
sion and the number of advanced HIV-related deaths, we
combine sexual behavior and HIV transmission into a single
parameter β that represents the rate of HIV infection for
susceptible individuals with chronically infected partners.
Due to a lack of data distinguishing sexual behavior in urban
and rural areas, we assume the same value ofβ for urban and
rural areas. Multiplicative factors θa and θt are used to take
into account the increased infectiousness of advanced HIV
patients and the decreased infectiousness of people on ART,
as described in (3). We assume identical population growth
rates, HIV-related death rates, rates of disease progression to
advanced HIV, and ART drop-out rate for both urban and
rural areas. The values used for these rates are based on the
best available international evidence for comparable settings
and are presented in Table 1.
Model parameter values associated with ART are impor-
tant in this analysis. Speciﬁcally, it was assumed that ART
reduces the infectiousness of HIV-infected people by 92%.
This is based on a recent meta-analysis [9]a n dap r o s p e c t i v e
cohort study [10] which each calculated a 92% reduction in
HIV transmission rates from heterosexual men and women
who are treated compared with those who are untreated. We
also assumed that in PNG 5% of people on ARTdie per year,
compared with 30% of people with advanced HIV disease
[11, 12].
2.2. Model Fitting and Calibration. The epidemic model is
calibrated against available data on HIV prevalence, HIV
incidence, the number of HIV diagnoses, and the number
of people on ART for PNG from 1990 to 2008 [2, 4]. To ﬁt
data, the valuesofβ, δc
u, δa
u, δc
r, δa
r, τu,a n dτr were varied over
timewhiletheotherparameters remainedconstant(Table1).
The population growth rate ρ and the urban-rural migration
rates νu and νr were ﬁxed for 1990–2008 to match World
Bank estimates and PNG Census data [13, 15].
The overall force of infection for HIV in PNG (Λ)
was estimated by adding the change in the number ofAIDS Research and Treatment 3
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Figure 1: Schematic diagram of the stages of HIV infection described by the model and the progression of people through these stages due
to infection, disease progression, diagnosis, and initiation of treatment. These stages are replicated for the urban and rural population in
PNG with migration(except forpeople on treatment) between corresponding infection stages. Peopleenter the uninfected population when
they become sexually active and leave the population due to natural or HIV-related mortality.
HIV-infected patients to the estimated number of HIV-
related deaths and dividing by the overall size of susceptible
population (3) .T h eﬁ t t e df o r c eo fi n f e c t i o nw a st h e nu s e d
to determine the value of β using (3)a n dt h ef a c tt h a t
Λ(Su + Sr) = ΛuSu + ΛrSr. The resulting ﬁtted value of
β has a value of 0.256 at the start of 1990, reaches a peak
value of 0.443 just prior to 2000, and then rapidly falls to a
minimum value of 0.064 by the end of 2008. The parameter
β refers to the probability of transmission occurring per year
in a long-term discordant partnership in which the HIV-
infected person is in the chronic stage; a range of 0.05–0.25
was reported among diﬀerent stratiﬁcations of discordant
partners in an African settings suggesting that our estimates
are not unrealistic [7].
The only diagnoses data available was the annual diag-
noses for all of PNG. We assumed values for the proportion
of diagnoses that occurin urban areas φu and the proportion
of diagnoses that occur in advanced HIV patients φa.U n t i l
1996 the only location for HIV testing in PNG was at the
Port Moresby General Hospital [3]. Since then, numerous
testing sites have been established across the country, but
urban residents still have more accessibility to HIV testing
facilities. This suggests that there should be no diagnoses
of HIV in rural areas until 1996; however, expert opinion
and anecdotal evidence suggests that many people travelled
to Port Moresby for HIV testing. Therefore, for ﬁtting and
simulation purposes, we assume 20% of HIV/AIDS infected
patients are from urban areas (slightly higher than the
proportion living in urban areas). In addition, we assume
that 75% of HIV diagnoses occur when an infected person
has developed advanced HIV symptoms. These assumptions
resultindiagnosesratesthatslowlyincreaseuntil2003before
rapidly increasing until the end of 2008, matching the actual
rapid expansion in HIV testing across PNG in recent years
[3]. The model-ﬁtted diagnoses rates were generally 2-3
times higher in urban areas and 2–4 times higher in the
advanced HIV population groups, which are consistent with
the perceived situation in the country. The ﬁtted testing
parameters values at the end of 2008 correspond to an
undiagnosed advanced HIV patient taking on average from
5t o1 6m o n t h st ob ed i a g n o s e di nu r b a na n dr u r a la r e a s ,
respectively.
Rates at which diagnosed chronic patients go onto
treatment (τu, τr) are calculated based on available data on
the number of people starting ART in PNG since 2004 when
ART ﬁrst became available. As there are no available data for
the location of residence for patients on ART, we assumed
that the rate at which diagnosed AIDS patients initiate ART
in urban areas is twice that in rural areas. The rates of
initiating treatment rapidly increase from zero in 2004 and
match the roll-out of ART services that cover an estimated
80% of treatment-eligible people in 2009 [2, 4].
Due to gaps in data and the absence of an eﬀective and
systematic reporting system, there are large uncertainties
surrounding HIV epidemiological data in PNG. To incor-
porate these uncertainties, we assume a range of ±10%4 AIDS Research and Treatment
Table 1: Deﬁnitions and value ranges for input and ﬁtting parameters used in our HIV transmissionmodel.
Parameter Description Value (Range) Footnote/
Reference
Demographic parameters
N0 Initial size of sexually active population 2,317,648 (a)
ρ Population growth rate 4.8% (4.7–4.9%)
α0 Initial proportion of population in urban areas 15%
(b) νu Migration rate from urban to rural settings 2.25% (2–2.5%)
νr Migration rate from rural to urban settings 0.2% (0.18–0.23%)
1/μ Average duration that a person remains in the sexually active population 45 years Assumed
HIV Biological parameters
β Rate at which susceptible individuals with partners that are chronically infected
become infected with HIV ﬁtted (±10%) (c)
θa Multiplicative increase in HIV transmissionprobability for partners with AIDS 5 (4–6) [7, 8]
θt
Multiplicative decrease in HIV transmissionprobability for HIV-infected partners
on eﬀective ART 0.08 (0.05–0.13) [9, 10]
γ Disease progression rate at which individuals chronically infected with HIV
progress to AIDS 0.075 (0.06–0.09) [7, 9]
μc Death rate per year for a person chronically infected with HIV 3% [11, 12]
μa Death rate per year for individuals with AIDS 30% [11, 12]
μt Death rate per year for HIV-infected individuals on ART 5% [11, 12]
Clinical parameters
δc
u Diagnosis rate for urban individuals with chronic infection ﬁtted (±10%)
(e) δa
u Diagnosis rate for urban individuals with AIDS ﬁtted (±10%)
δc
r Diagnosis rate for rural individuals with chronic infection ﬁtted (±10%)
δa
r Diagnosis rate for rural individuals with AIDS ﬁtted (±10%)
τu Rate at which urban individuals diagnosed with AIDS begin treatment ﬁtted (±10%) (f)
τr Rate at which rural individuals diagnosed with AIDS begin treatment ﬁtted (±10%)
1/ω Average duration at which individuals remain on ART 10 years (6.7–20 years) (g)
(a)To calibrate the model to the HIV epidemic in PNG from 1990 to 2010, the sexually active population size was assumed to be equal to the 15–49-year-old
adult population estimated by the World Bank [13]. From the initial 1990 population, the value of ρ (which is assumed to be the same for urban and rural
areas) is set to match the growth of the 15–49-year-old population seen in PNG from 1990 to 2008 [13].
(b)Data from the World Bank gives the proportion of the population that is living in urban areas to be approximately 15%. However, the proportion of the
population in urban areas has been declining very slightly from 1990 to 2008 [13]. The migration rates between urban and rural areas are set to follow this
trend afterthe urban proportion is set to be initially15%.
(c)This rateincorporates the numberof sexualpartners, condom usage,eﬀectof STIs, and other factors thataﬀectHIV transmission.As weare focusedon the
impact of ART reductions, we group these factors into a single rate which is then ﬁtted to the annual prevalence and incidence estimates for PNG. The value
of β is likely to be diﬀerent for urban and rural areas; however, there is limited data available for these population categories so we have assumed the same
value for ﬁtting purposes.
(d)The value and range for γ have been used to match the estimates for the number of people who require ART in PNG. The disease progression rate we use
corresponds to an average duration of being chronically infected equal to 11–16.6 years which is much longer than established durations for low resource
settings[14]. Due to the simplicityof our HIV transmissionmodel, which only has one infection stage prior to AIDS, a longer average time period is required
to match the actual epidemiology.
(e)The rate at which infected people are diagnosed is ﬁtted to match the overall number of diagnoses recorded in PNG [2].
(f)The rate at which individuals diagnosed with AIDS begin treatment is ﬁtted to match the overall number of people who have started treatment since 2003,
the estimated number of people who require treatment, and the ART coverage in PNG [2, 4].
(g)The average durationat which urban and rural people remain on ART is likelyto be diﬀerentdue to supplyand logisticalissues.However, there isvery little
data on the length of time people remain on ART in PNG; hence, we have assumed the same value and range for urban and rural areas.
for each of the ﬁtted parameter values (see Table 1). One
hundred parameter sets were used in the analysis, sampled
(through Latin hypercube sampling implemented in the
SaSAT computer program [16]) from the parameter ranges
speciﬁed in Table 1 (Figure 2).
2.3. ART Reduction Scenarios. To understand the future
impact of ART reductions in PNG, we considered four
scenarios. These were simulated by our model for the next
ﬁve years for each of our parameter sets. These scenarios are
speciﬁed by the number of people on ART. The scenarios are
as follows:
(i) continual roll-out of ART which extend current
trends in PNG. This is the baseline scenario used
for comparison with other scenarios and is simulatedAIDS Research and Treatment 5
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Figure 2: Fitting and calibration of the HIV transmission model to PNG epidemiological data from 1990 to 2009. In each ﬁgure, estimates
ordata from the PNG NationalDepartment of Health (black discs, data) are compared with 100 model-based simulations(red) and median
simulations(blue) over the period from 1990 to 2009. (a) HIV prevalence in adult population. (b) HIV incidence each year per 100persons.
(c) Number of HIV diagnoses each year. (d) The cumulative number of HIV-infected people who have started antiretroviral treatment by
the end of each year.
by extending the period of simulation with the
parameters ﬁxed to their values at the end of 2009,
(ii) ﬁxing the number of people on ART to a constant
value as at the end of 2009. This represents a
consistent supply ofART in PNG that sustains a ﬁxed
number of people on ART into the future,
(iii) reducing the number ofHIV-infected people on ART
by 50% by 2015,
(iv) reducing the number ofHIV-infected people onART
by 90% by 2015.
The variation in number of people on ART from the end
of2009foreachofthesescenariosisshowninFigure3(a).W e
also investigated two scenarios where the reduction in ART
services only lasted for two years before the re-establishment
of the current ART roll-out (potentially due to a successful
funding application in the next Global Fund round in 2011).
In these two scenarios, the parameter values were set to the
valuesin scenario (iii)and (iv),respectively, before returning
to their current values after two years. The number of people
on ART follows the same trend as the (iii) and (iv) scenarios
for two years before rapidly increasing towards the expected
number under current conditions.
3.Resultsand Discussion
Using our mathematical model we evaluated the impact of
reductions in ART roll-out in PNG by forecasting the change
in expected HIVincidenceand advanced HIVdeaths in PNG
over the 5 years for each scenario. Our results show that a
reduction in ART availability in PNG is likely to have a large
and signiﬁcant impact on the HIV epidemic.
3.1. Increase of Annual HIV Incidence. Our model predicts
that a continual roll-out of ART in PNG would result in a
declining trend in HIV incidence. The annual HIV incidence
is predicted to reduce from a median of 2,794 infections
(0.074 per 100 person-years, IQR 2,227–3,360) in 2009 to
2,674 infections in 2014 (0.062 per 100 person-years, IQR
2,109–3,239)(Figure3(b)).Ifthecontinualroll-outofARTis
interruptedin2010,thenalargeriseinannual HIVincidence
is expected (Figure 3(b)). Forthe scenario where the number
of ART patients remains at a constant level after 2009, the
expected number of new HIV infections in 2014 will be
4,253 (0.099 per 100 person-years, IQR 3,264–5,242) which
is a 59% increase from the baseline level. If the number of
people on ART is reduced by 50% or 90%, then incidence is
forecasted to increase to 4,490 (0.10% per 100 person-years,6 AIDS Research and Treatment
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Figure 3: The impact of reductions in ART availability. (a) Median number of HIV-infected people receiving ART for scenarios from (i) to
(iv) in the text. These scenarios were a continuation of the ART roll-out after 2009, maintaining ART services so that the number of people
who receive ART remains constant, a reduction in the number of people receiving treatment of 50% from the level at the end of 2009, and
a reduction in the number of people receiving treatment of 90% from the level at the end of 2009. (b) Median annual incidence per 100
person-years after 2009 for 100 simulations of each of the scenarios considered. (c) Total number of advanced HIV deaths for the period
2010–2014 for all the scenarios considered. The blue bars represent the median number of deaths for scenarios from (i) to (iv) in the text
with the black error bars showingthe minimum and maximumnumber of deaths for 100 model simulationsof each scenario. Similarly, the
red bars represent the median number of deaths for the scenarios where ART programs and services are interrupted for two years.
IQR 3,382–5,599) and 5,323 (0.12% per 100 person-years,
IQR 4,035–6,610) in 2014, which, correspond to 67.9%, and
99.1%increases,respectively.Cumulatively,forscenarios(ii),
(iii), and (iv), 4,871, 7,181, and 10,934 additional HIV cases
(compared to baseline) are estimated to occur during 2010–
2014 for these scenarios. Further, if ART availability remains
low beyond 2015, higher incidence levels will likely result. If
the 50% and 90% reductions in ART are only in eﬀect for
two years, there is still a substantial increase in the expected
incidenceover the two-year period before declining to a level
slightly above forecasts for current conditions. According to
these two scenarios, it could be expected that ∼3,298 and
5,342additional HIVcases(compared tobaseline) will occur
during 2010–2014 period, respectively.
This increase in incidence is likely to be an upper bound
as the sexual behavior and prevalence of other sexually
transmitted infections (STIs) aﬀecting HIV transmission
are assumed to be constant in our model; however, these
factors are implicitly incorporated in our epidemiological
ﬁtting routine. In reality, sexual behavior could changeAIDS Research and Treatment 7
due to the continuation of other education and prevention
programs or because people are sick with advanced HIV.
Furthermore, the level of STIs in the population is expected
to change with the expansion of voluntary counseling and
testing services and targeted treatment programs. On the
other hand, many of these programs could also be aﬀected
by decreases in HIV funding potentially leading to larger
increases in incidence. By only focusing on ART, our results
show the relative impact of reductions in ART availability
on the PNG HIV epidemic. The eﬀect of other factors that
could also change requires separate evaluation; however, the
direction and impact of decreases in funding on these factors
are unknown.
3.2. Increase of Advanced HIV-Related Deaths. With the
continuation of the current ART roll-out, the total number
ofadvancedHIVdeathsinPNGover2010–2014isforecasted
to be 6,402, (range 3,714–12,221) which corresponds to an
average annual death rate of 1.52% in the population of
people living with HIV. Figure 3(c) highlights the severe
increase in the number of advanced HIV deaths resulting
from a reduction in ART availability. Our model predicts an
additional 2,975 (range 1,783–5,333) advanced HIV deaths
between the beginning of 2010 and the end of 2014 if
the supply of ART is maintained at the current level. This
corresponds to a 46.5% increase in the number of advanced
HIV deaths in comparison with the continuous ART roll-
out scenario. Further, for the scenarios where the number of
patients on ART reduces to 50% and 10% of the 2009 level,
the median number of cumulative deaths over the period
2010–2014 will increase to 10,936 (range 6,047–20,891) and
12,848 (range 7,392–24,232), which correspond to 70.8%
and 100.7% rise, respectively. This lifts the advanced HIV
death rates of HIV-infected individuals to 2.5% and 2.9%
per year. When ART supplies are only interrupted for two
years the median number of cumulative deaths over the
period 2010–2014 is projected to increase to 8,300 (range
4,651–15,969) and 9,299 (range 5,323–17,786) for the 50%
reduction and 90% reduction scenarios, respectively. A large
reduction over this short period results in almost as many
deaths as maintaining the supply of ART at the current level
(Figure 3(c)).
4.Conclusions
The HIV epidemic in PNG has been in a large expansion
phase overthe past 15 years. Althoughthe prevalence ofHIV
has likely started to reach a plateau, prevention and control
measures require renewed eﬀorts. Thus far, the epidemic has
resulted in an estimated 38,000 people becoming infected
with HIV in PNG with over 28,000 of these diagnosed.
To remain healthy, these people require clinical care and
management of their infection and access to eﬀective com-
bination antiretroviral therapy. As a lower income country,
PNG has not been able to ﬁnance the required antiretroviral
drugs for its citizens and has depended on external funding
for its ART programs. Unfortunately, PNG recently did not
secure external funding for the continuation of these vital
programs and the Papua New Guinean government had to
allocate funding from already constrained health budgets
to continue the roll-out of ART. Without funding, ART
availability in PNG would not increase according to scale-up
plans and could decrease very substantially.
In this study, we used a mathematical model to demon-
strate that if ART supplies are not funded and declined,
then substantial population-level impacts could be expected
in PNG. Speciﬁcally, if the number of people on ART falls
to 10% of current level, then over the next 5 years there
could be an approximate doubling in annual incidence
and an additional 12,848 AIDS-related deaths. Even if ART
provision is halved then annual incidence would increase
by ∼68% and there would be an additional ∼10,936 AIDS-
related deaths.
The model we developed was calibrated to accurately
reﬂect the unique epidemiology of PNG at the overall
population-level and was based on the best data available;
however, it isa relatively simple modeland couldnotcapture
t h ef u l ld e g r e eo fc o m p l e x i t ya n dh e t e r o g e n e i t yt h a te x i s t s
within the population. In particular, the model did not
capturethemovementofHIV-positive peopleaccurately,did
not investigate the impact on particular at risk population
groups suchas commercialsex workers, and didnot consider
treatment failure and the possible increased emergence of
drug-resistant strains of HIV. Regardless, the model is useful
for obtaining the population-level relative change in new
incident cases and AIDS-related deaths that could result due
to a drug shortage in PNG. These results highlight the large
degree of crisis for people at risk of or living with HIV
in PNG and their families and community. This crisis also
aﬀects other concerning health issues such as tuberculosis;
the HIV prevalence in tested tuberculosis patients is ∼3.5%
in PNG [2]. A similar population-level relative impact could
be expected for other low and middle income settings that
rely on external funding for ART supplies if their ART
funding were to reduce signiﬁcantly.
The majority of funds for HIV prevention, care, and
treatment in PNG are externally funded from the Global
Fund, international government developmentorganizations,
and nongovernment organizations. While PNG’s economy
has experienced relatively strong growth, many international
organizations suﬀered a reduction in funding after the
2008 global ﬁnancial crisis which could lead to impacts on
HIV/AIDS epidemics [17, 18]. A judicious mix of funding
sources and disbursement channels could be important for
responding to HIV epidemics in PNG [19]. This includes
the PNG government which may need to consider taking
greater responsibility for funding HIV programs to reduce
exposure of these programs to external volatility, especially
since Government expenditure for HIV has decreased in
recent years. Irrespective of funding sources, it must be
acknowledged that there could be a state of emergency for
people living with HIV in PNG. People with late-stage HIV
infections do not have access to eﬀective ART and are at
real risk of premature death. Therefore, it is of very high
importance that funding for HIV programs are obtained
and that appropriate administration processes are put in
place to handle any funds procured and manage the logistics8 AIDS Research and Treatment
of channeling ART for eﬀective distribution. In addition,
improvements in infrastructure are required to reach and
care for people with HIV in PNG. These complex factors
need to be addressed in PNG and in other similar low-
resource settings in the process of reaching a major goal of
achievinguniversal treatment accessforall peopleliving with
HIV.
Acknowledgments
The authors thank Dr. Uarang Kitur from the PNG National
Department of Health for providing them with the latest
NationalDepartmentofHealthreportscontainingPNGHIV
epidemiology data and EPP estimates of HIV prevalence and
incidence. This study was funded by the following sources:
the Australian Agency for International Development of
the Department of Foreign Aﬀairs and Trade (AusAID),
Grant number630495fromtheNationalHealthand Medical
Research Council, and the Australian Government Depart-
ment of Health and Ageing. The views expressed in this
publication do not necessarily represent the position of
the Australian Government. NCHECR is aﬃliated with the
Faculty of Medicine, University of New South Wales.
References
[1] “Oceania AIDS Epidemic Update: Regional Summary,” Joint
United Nations Programme on HIV/AIDS and World Health
Organization, 2008.
[2] “The 2008 STI , HIV and AIDS annual surveillance report,”
PNG National Department of Health, 2009.
[3] “The 2007 Estimation Report on the HIV Epidemic in Papua
New Guinea,” PNG National AIDS Council, 2008.
[4] I. Kitur, “An update on of the HIV situation in Papua
New Guinea: the facts and the trends,” in Proceedings of the
Australasian HIV/AIDS Conference, Brisbane, Australia, 2009.
[5] D. Mellor, “Asian Development Outlook 2009: Rebalanc-
ing Asia’s Growth,” edited by Asian Development Bank,
pp. 274–284, 2010, http://www.adb.org/Documents/Books/
ADO/2009/.
[6] “Country Health Information Proﬁles - Papua New Guinea,”
World Health Organization, 2010, http://www.wpro.who.int/
countries/2009/png/.
[7] T. C. Quinn, M. J. Wawer, N. Sewankambo et al., “Viral load
and heterosexual transmission of human immunodeﬁciency
virus type 1,” New England Journal of Medicine, vol. 342, no.
13, pp. 921–929, 2000.
[ 8 ] D .P .W i l s o n ,M .G .L a w ,A .E .G r u l i c h ,D .A .C o o p e r ,a n dJ .M .
Kaldor, “Relation between HIV viral load and infectiousness:
a model-based analysis,” The Lancet, vol. 372, no. 9635, pp.
314–320, 2008.
[9] S.Attia,M.Egger,M.M¨ uller,M.Zwahlen,andN.Low,“Sexual
transmissionof HIV according to viral load and antiretroviral
therapy: systematic review and meta-analysis,” AIDS, vol. 23,
no. 11, pp. 1397–1404, 2009.
[10] D. Donnell, J. M. Baeten, J. Kiarie et al., “Heterosexual HIV-
1 transmission after initiation of antiretroviral therapy: a
prospective cohort analysis,” The Lancet, vol. 375, no. 9731,
pp. 2092–2098, 2010.
[11] B. Ledergerber, J. D. Lundgren, S. Walker et al., “Predictors
of trend in CD4-positive T-cell count and mortality among
HIV-1-infected individuals with virological failure to all three
antiretroviral-drug classes,”Lancet, vol. 364, no. 9428, pp. 51–
62, 2004.
[12] C. Smith, “Causes of death in the D:A:D study-initial results,”
2008.
[13] “The World Bank Data Catalog,” 2010, http://data.worldbank
.org/country/papua-new-guinea.
[14] K. Porter and B. Zaba,“The empirical evidence for the impact
of HIV on adult mortality in the developing world: data from
serological studies,” AIDS, vol. 18, no. 2, pp. S9–S17, 2004.
[15] “Papua New Guinea 2000 Census National Report”.
[16] A. Hoare, D. G. Regan, and D. P. Wilson, “Sampling and sen-
sitivity analyses tools (SaSAT) for computational modelling,”
Theoretical Biology and Medical Modelling,v o l .5 ,a r t i c l en o .4 ,
2008.
[17] “Averting a human crisis during the economicdownturn:pol-
icy options from the World Bank’s Human Development Net-
work,” May 2009, http://siteresources.worldbank.org/NEWS/
Resources/AvertingTheHumanCrisis.pdf.
[ 1 8 ]R .T .G r a y ,K .J .H e y m e r ,A .H o a r ee ta l . ,“ W h a ti m p a c tm i g h t
theeconomiccrisishaveonHIVepidemicsinSoutheastAsia?”
Current HIV Research, vol. 7, no. 6, pp. 656–665, 2009.
[19] C. V. Mean and P. Godwin, “Funding the HIV/AIDS pro-
gramme in Cambodia: the experience of the health sector,” in
Proceedings oftheInternationalConferenceonAIDS,Barcelona,
Spain, 2002, abstract no. G12759.